We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-12.77%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$44.2B
AUM Growth
-$8.44B
(-16%)
Cap. Flow
-$301M
Cap. Flow
% of AUM
-0.68%
Top 10 Holdings %
Top 10 Hldgs %
14.01%
Holding
2,360
New
150
Increased
1,005
Reduced
998
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$209M |
| 2 |
CVS Health
CVS
|
+$195M |
| 3 |
Tyson Foods
TSN
|
+$136M |
| 4 |
ExxonMobil
XOM
|
+$135M |
| 5 |
LyondellBasell Industries
LYB
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$239M |
| 2 |
Microsoft
MSFT
|
+$204M |
| 3 |
Johnson & Johnson
JNJ
|
+$157M |
| 4 |
Amazon
AMZN
|
+$144M |
| 5 |
Walmart Inc
WMT
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.23% |
| 2 | Healthcare | 16.49% |
| 3 | Financials | 11.74% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Idacorp
IDA
$8.08B
| $20.8M | 0.05% |
196,031
-22,840
| -10% | -$2.47M |
|
477
Bath & Body Works
BBWI
$3.89B
| $20.7M | 0.05% |
796,764
-302,695
| -28% | -$13.1M |
|
478
Eastman Chemical
EMN
$8.39B
| $20.7M | 0.05% |
234,308
+137,361
| +142% | +$14.2M |
|
479
Wintrust Financial
WTFC
$10.7B
| $20.7M | 0.05% |
264,477
+99,615
| +60% | +$8.58M |
|
480
AvalonBay Communities
AVB
$26.3B
| $20.7M | 0.05% |
107,107
-17,053
| -14% | -$3.69M |
|
481
Vistra
VST
$48B
| $20.6M | 0.05% |
904,020
+699,915
| +343% | +$17.3M |
|
|
JHG
482
DELISTED
Janus Henderson
JHG
| $20.6M | 0.05% |
904,557
+36,584
| +4% | +$1.05M |
|
483
Brink's
BCO
$4.55B
| $20.5M | 0.05% |
348,721
+271,090
| +349% | +$16.3M |
|
484
Columbia Sportswear
COLM
$2.92B
| $20.4M | 0.05% |
286,827
-135,003
| -32% | -$10.8M |
|
485
XPeng
XPEV
$11.5B
| $20.4M | 0.05% |
642,882
-11,278
| -2% | -$290K |
|
486
Seagate
STX
$182B
| $20.4M | 0.05% |
290,034
+144,918
| +100% | +$11.8M |
|
487
Alliant Energy
LNT
$17.7B
| $20.3M | 0.05% |
348,032
+40,625
| +13% | +$2.45M |
|
488
Gates Industrial Corporation Ltd.
GTES
$7.19B
| $20.3M | 0.05% |
1,923,264
+800,524
| +71% | +$10M |
|
489
Intuitive Surgical
ISRG
$139B
| $20.3M | 0.05% |
102,288
-268
| -0.3% | -$62.9K |
|
490
NiSource
NI
$20B
| $20.2M | 0.05% |
687,736
+107,852
| +19% | +$3.27M |
|
491
Morgan Stanley
MS
$338B
| $20.2M | 0.05% |
269,298
-125,861
| -32% | -$10.3M |
|
492
Qualys
QLYS
$6.43B
| $20.2M | 0.05% |
161,165
-2,520
| -2% | -$330K |
|
493
ResMed
RMD
$31.9B
| $20.2M | 0.05% |
96,129
-74,266
| -44% | -$15.8M |
|
494
Donaldson
DCI
$11.2B
| $20.1M | 0.05% |
424,925
+4,642
| +1% | +$234K |
|
495
Bank OZK
OZK
$5.63B
| $20M | 0.05% |
548,600
+236,021
| +76% | +$9.31M |
|
496
Kilroy Realty
KRC
$4.32B
| $20M | 0.05% |
391,598
+11,018
| +3% | +$699K |
|
497
Digital Realty Trust
DLR
$70.8B
| $19.8M | 0.04% |
152,540
-3,905
| -2% | -$539K |
|
|
SIVB
498
DELISTED
SVB Financial Group
SIVB
| $19.8M | 0.04% |
52,279
-91,098
| -64% | -$42.9M |
|
499
Marriott Vacations Worldwide
VAC
$3.89B
| $19.8M | 0.04% |
173,457
+23,189
| +15% | +$3.26M |
|
500
Berkshire Hathaway Class A
BRK.A
$1.13T
| $19.6M | 0.04% |
48
-9
| -16% | -$4.24M |
|
Similar funds
VGA
AQR Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, AQR Capital Management held 2,360 positions worth $44.2B, down 16% from $52.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AQR Capital Management's Q2 2022 filing shows 150 new, 1,005 increased, 998 reduced and 187 closed positions. Its largest new stake was Fluor: 339,891 shares worth $7.86M. The largest sale was Thermo Fisher Scientific, an estimated $239M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q2 2022 buy was Fluor: 339,891 shares worth $7.86M.
- AQR Capital Management added most to Gilead Sciences in Q2 2022, an estimated $209M increase.
- AQR Capital Management's biggest Q2 2022 reduction was Thermo Fisher Scientific, cutting an estimated $239M.
- AQR Capital Management fully exited Roku in Q2 2022, selling an estimated $32.5M.
- AQR Capital Management's ten largest holdings make up 14% of its $44.2B portfolio in Q2 2022.
- AQR Capital Management opened 150 new positions and closed 187 in Q2 2022.
- AQR Capital Management's portfolio value fell 16% quarter-over-quarter to $44.2B.
Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.